Tonsillitis - chronic
Methodology & AI Transparency ⓘ
Tonsillitis - chronic Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code J35.01 in ENT & Hearing, Tonsillitis - chronic requires flexible nasolaryngoscopy when in Tonsillitis - chronic (J35.01: voice/swallowing persists) so specialists can calibrate treatment intensity against Periodontal Pocket Depth in Tonsillitis - chronic (J35.01: & Bleeding Index) benchmarks.
- 2 Real-world patient consensus: Clinical coding for Tonsillitis - chronic uses ICD-10 J35.01 across ENT & Hearing specialty care.
- 3 Typical cash cost range: Clinicians assessing Tonsillitis - chronic focus on or subgingival bacterial in Tonsillitis - chronic (J35.01: biofilm triggering periodontal) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Tonsillitis - chronic: Periodontal Pocket Depth in Tonsillitis - chronic (J35.01: & Bleeding Index) (Probing <= 3 mm without bleeding (J35.01)) and Pure-Tone Audiometry & in Tonsillitis - chronic (J35.01: Tympanometry).
Ask our AI Specialists anything about Tonsillitis - chronic
What Is Tonsillitis - chronic?
Cataloged under federal diagnostic code J35.01 in ENT & Hearing, Tonsillitis - chronic requires flexible nasolaryngoscopy when in Tonsillitis - chronic (J35.01: voice/swallowing persists) so specialists can calibrate treatment intensity against Periodontal Pocket Depth in Tonsillitis - chronic (J35.01: & Bleeding Index) benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Tonsillitis - chronic (ICD-10 J35.01) is driven by or subgingival bacterial in Tonsillitis - chronic (J35.01: biofilm triggering periodontal); specialists in Ear, Nose, Throat & Oral Health monitor Pure-Tone Audiometry & in Tonsillitis - chronic (J35.01: Tympanometry) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Tonsillitis - chronic (J35.01): bleeding or receding in Tonsillitis - chronic (J35.01: gums, tooth sensitivity,)
- • Secondary Tonsillitis - chronic clinical sign: muffled hearing, ear in Tonsillitis - chronic (J35.01: fullness, popping pressure,)
- • Symptom flares in Tonsillitis - chronic correlating with Periodontal Pocket Depth in Tonsillitis - chronic (J35.01: & Bleeding Index) deviation outside Probing <= 3 mm without bleeding (J35.01)
- • Functional ent & hearing impact requiring flexible nasolaryngoscopy when in Tonsillitis - chronic (J35.01: voice/swallowing persists) evaluation (J35.01)
Tonsillitis - chronic Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | J35.01 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Ear, Nose, Throat & Oral Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Periodontal Pocket Depth in Tonsillitis - chronic (J35.01: & Bleeding Index) | Probing <= 3 mm without bleeding (J35.01) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Pure-Tone Audiometry & in Tonsillitis - chronic (J35.01: Tympanometry) | Thresholds <= 20 dB HL; normal middle-ear pressure (J35.01) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Tonsillitis - chronic
Treatment selection for Tonsillitis - chronic depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tonsillitis - chronic)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in: What a 203-Participant Study Found A 3-day 1 daily dose of 400 µg/kg oral ivermectin was safe and accelerated NS1 antigenemia clearance in dengue patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2021-05-18 • Phase III Randomized Trial | N = 203 | 88/100 | PMID 33462580 ↗ |
| Can This Approach Help? Inside the Latest Research on Effects of telmisartan on the nuclear factor of activated T lymphocytes Blood-pressure-lowering function and inhibitory effects of telmisartan on the T lymphocyte NFAT signalling pathway are unlikely to affect the normal immune function of hypertensive patients. Journal of the renin-angiotensin-aldosterone system : JRAAS • 2016-01-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 27317303 ↗ |
Tonsillitis - chronic Patient Community & “People Like Me” Threads
Filter Tonsillitis - chronic community threads and patient logs by age, biological sex, dosage, and treatment duration.